[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Nuvation Bio Inc (NUVB)

Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nuvation Bio Inc 1500 BROADWAY SUITE 1401 NEW YORK NY 10036 USA

www.nuvationbio.com Employees: 298 P: 332-208-6102

Sector:

Medical

Description:

Nuvation Bio Inc. is a biopharmaceutical company. It engages in developing differentiated and novel therapeutic candidates for unmet needs in oncology. Nuvation Bio Inc., formerly known as Panacea Acquisition Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 2,338,479
Enterprise Value, $K 2,227,319
Shares Outstanding, K 351,123
Float, K 245,400
% Float 69.89%
Short Interest, K 53,424
Short Float 15.22%
Days to Cover 8.70
Short Volume Ratio 0.51
% of Insider Shareholders 30.11%
% of Institutional Shareholders 61.67%

Financials:

Annual Sales, $ 62,900 K
Annual Net Income, $ -204,630 K
Last Quarter Sales, $ 31,690 K
Last Quarter Net Income, $ -62,840 K
EBIT, $ -137,630 K
EBITDA, $ -135,230 K

Growth:

1-Year Return 128.08%
3-Year Return 306.10%
5-Year Return -32.73%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -160.87%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.15 on 08/06/26
Next Earnings Date 11/02/26
Earnings Per Share ttm -0.41
EPS Growth vs. Prev Qtr -1,600.00%
EPS Growth vs. Prev Year 11.76%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NUVB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -46.59%
Return-on-Assets % -22.01%
Profit Margin % -325.33%
Debt/Equity 0.02
Price/Sales 39.02
Price/Cash Flow N/A
Price/Book 9.63
Book Value/Share 0.73
Interest Coverage -13.96
60-Month Beta 1.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.